Drug Use Investigation For HIV Infection Patients Of Mycobutin (Regulatory Post Marketing Commitment Plan)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Jan 2016
At a glance
- Drugs Rifabutin (Primary)
- Indications Mycobacterial infections; Mycobacterium avium complex infections; Tuberculosis
- Focus Adverse reactions
- Sponsors Pfizer
- 05 Jan 2016 Planned End Date changed from 1 Apr 2018 to 1 May 2018 as reported by ClinicalTrials.gov record.
- 05 Jan 2016 Planned primary completion date changed from 1 Apr 2018 to 1 May 2018 as reported by ClinicalTrials.gov record.
- 30 Jul 2015 Planned End Date changed from 1 Mar 2018 to 1 Apr 2018 as per ClinicalTrials.gov record.